Long-term safety of repeated cycles of rozanolixizumab treatment in patients with generalized myasthenia gravis

Repeated cycles of rozanolixizumab treatment in patients with muscle-specific kinase autoantibody-positive generalized myasthenia gravis

Subcutaneous rozanolixizumab in pediatric patients with generalized myasthenia gravis: Clinical study design

Effect of zilucoplan on disease fluctuation in patients with generalized myasthenia gravis in the Phase 3 RAISE study

Response rates with zilucoplan among patients with generalized myasthenia gravis in an interim analysis of RAISE-XT, a Phase 3 open-label extension study

Effect of zilucoplan on fatigue in generalized myasthenia gravis in the Phase 3 RAISE and RAISE-XT studies